Why is 3B Blackbio falling/rising?

As of 10-Jul, 3B Blackbio DX Ltd is experiencing a decline in its stock price, currently at 1,523.15, which reflects a decrease of 100.85 or 6.21%. Today's price summary indicates that the stock underperformed its sector by 5%, touching an intraday low of Rs 1510, which is a drop of 7.02%. The stock's performance over the past week shows a slight increase of 0.94%, but it has seen a significant decline of 7.80% over the past month. Despite generating a return of 35.13% over the last year, the company has reported flat results in March 2025, with a notable drop in profit before tax and operating profit margins, contributing to a perception of overvaluation with a high Price to Book Value ratio. Additionally, the lack of domestic mutual fund investment may indicate a lack of confidence in the stock's current price.
In the broader market context, while the Sensex has remained relatively stable with a slight decrease of 0.06% over the past week, 3B Blackbio's recent performance contrasts sharply with the benchmark, particularly in the longer term, where it has underperformed significantly year-to-date with a decline of 23.02% compared to the Sensex's increase of 6.46%. This divergence highlights the challenges faced by 3B Blackbio, including falling investor participation, as evidenced by a 43.97% drop in delivery volume against the five-day average. The stock's liquidity remains adequate for trading, but the overall sentiment appears to be weighed down by recent financial results and valuation concerns.